BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22045792)

  • 1. Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.
    Putora PM; Benz G; Rodriguez R; Brutsche M; Früh M
    Eur Respir J; 2011 Nov; 38(5):1228-30. PubMed ID: 22045792
    [No Abstract]   [Full Text] [Related]  

  • 2. Gefitinib: a cause of pyogenic granulomalike lesions of the nail.
    High WA
    Arch Dermatol; 2006 Jul; 142(7):939. PubMed ID: 16847224
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of pyogenic granulomas following gefitinib therapy with partial matricectomy and phenolization.
    Dika E; Balestri R; Vaccari S; Alessandro Fanti P; Misciali C; Patrizi A
    J Dermatolog Treat; 2009; 20(6):374-5. PubMed ID: 19954397
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cutaneous toxicity following treatment with gefitinib (ZD1839).
    Pascual JC; Belinchón I; Sivera F; Yuste A
    Br J Dermatol; 2005 Dec; 153(6):1222-3. PubMed ID: 16307664
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas.
    Panariello L; Caro G; Bianca D; Fabbrocini G
    G Ital Dermatol Venereol; 2015 Dec; 150(6):755-6. PubMed ID: 26513046
    [No Abstract]   [Full Text] [Related]  

  • 6. Erlotinib for pretreated squamous cell carcinoma of the lung in Japanese patients.
    Hata A; Katakami N; Kunimasa K; Yoshioka H; Fujita S; Kaji R; Tachikawa R; Tomii K; Imai Y; Iwasaku M; Ishida T
    Jpn J Clin Oncol; 2011 Dec; 41(12):1366-72. PubMed ID: 22058419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erlotinib-induced bullous pemphigoid.
    Stingeni L; Bianchi L; Minotti V; Lisi P
    J Am Acad Dermatol; 2012 Nov; 67(5):e199-201. PubMed ID: 23062911
    [No Abstract]   [Full Text] [Related]  

  • 8. Erlotinib and maintenance therapy of non-small cell lung cancer. Inadequate assessment; authorisation unjustified.
    Prescrire Int; 2011 Oct; 20(120):234. PubMed ID: 21970082
    [No Abstract]   [Full Text] [Related]  

  • 9. APL during gefitinib treatment for non-small-cell lung cancer.
    Uchida A; Matsuo K; Tanimoto M
    N Engl J Med; 2005 Feb; 352(8):843. PubMed ID: 15728826
    [No Abstract]   [Full Text] [Related]  

  • 10. Erlotinib-induced skin manifestations.
    Motoki T; Mitsuishi T; Kawana S
    J Dermatol; 2009 Dec; 36(12):658-9. PubMed ID: 19958452
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
    Eames T; Landthaler M; Karrer S
    Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erlotinib-induced acneiform rash not affecting previously irradiated skin].
    Eguren C; Domínguez-Fernández I; Santiago-Sánchez-Mateos DI; García-Díez A
    Actas Dermosifiliogr; 2010 Mar; 101(2):186-7. PubMed ID: 20223168
    [No Abstract]   [Full Text] [Related]  

  • 13. Erlotinib-associated dermatological toxicity.
    Mumoli N; Cei M; Vitale J
    QJM; 2013 Apr; 106(4):363-4. PubMed ID: 22927541
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer.
    Kobayashi T; Koizumi T; Agatsuma T; Yasuo M; Tsushima K; Kubo K; Eda S; Kuraishi H; Koyama S; Hachiya T; Ohura N
    Cancer Chemother Pharmacol; 2012 May; 69(5):1241-6. PubMed ID: 22278730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subungueal pyogenic granuloma secondary to docetaxel therapy.
    Devillers C; Vanhooteghem O; Henrijean A; Ramaut M; de la Brassinne M
    Clin Exp Dermatol; 2009 Mar; 34(2):251-2. PubMed ID: 19120399
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyogenic granuloma caused by afatinib: Case report and review of the literature.
    Inoue A; Sawada Y; Nishio D; Nakamura M
    Australas J Dermatol; 2017 Feb; 58(1):61-62. PubMed ID: 26603180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib. Still no convincing results in non-small cell lung cancer.
    Prescrire Int; 2010 Jun; 19(107):113. PubMed ID: 20738034
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermal growth factor receptor inhibitors, gefitinib and erlotinib (Tarceva , OSI-774), in the treatment of bronchioloalveolar carcinoma.
    DeGrendele H
    Clin Lung Cancer; 2003 Sep; 5(2):83-5. PubMed ID: 14596689
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyogenic Granuloma in a Patient on Gefitinib.
    Massa A; Antunes A; Varela P
    Acta Med Port; 2016 Jun; 29(6):416. PubMed ID: 27865223
    [No Abstract]   [Full Text] [Related]  

  • 20. Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma.
    Garfield DH
    J Clin Oncol; 2005 Oct; 23(30):7738-40. PubMed ID: 16234533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.